Skip to content

EXTRA-Meso (EXercise TheRApy in Mesothelioma) Feasibility

EXercise TheRApy in Mesothelioma - A Feasibility Study

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06491784
Enrollment
40
Registered
2024-07-09
Start date
2024-01-25
Completion date
2025-07-31
Last updated
2024-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mesothelioma

Brief summary

The goal of this clinical trial is to learn whether running an exercise study in patients with mesothelioma is feasible. The main question(s) it aims to answer are: 1. Is it feasible to recruit patients to a randomised clinical trial of exercise therapy 2. What are the barriers to study recruitment 3. What are the barriers to study retention Participants who decide to take part in the study will be randomly allocated one of two study arms: 1. Standard of care, where the participant will undergo their usual clinical follow-up 2. Exercise therapy, where the participant will receive a personalised 12 week exercise, nutrition and wellbeing programme Participants in both study arms will be asked to complete quality of life questionnaires and a basic fitness assessment at the start and end of the study follow-up period. Participants will be asked if they would be happy to conduct a short interview with a member of the research team, to assess their views on the study. This interview will be audio recorded and the audio recording will be transcribed anonymously to allow researchers to improve future study design.

Detailed description

The aim of this study is to examine the feasibility of a randomised trial of exercise therapy in Mesothelioma. It will define likely rate of recruitment based on performance in two mesothelioma centres and identify barriers to recruitment and retention. Outcomes from the study will help refine the design of a future definitive phase 3 trial. That future phase 3 trial will have a patient-centred primary endpoint, e.g. a meaningful improvement in Health Related Quality of Life (HRQOL) or an increase in treatment uptake or tolerance. Additional outcome measures are likely to include functional fitness, hospital admissions and overall survival. A randomised prospective feasibility study will be performed over 12 months in two centres in the United Kingdom (Glasgow and Manchester). If eligible for the study, patients will be randomised 1:1 to receive a personalised exercise programme or standard care. Patients randomised to the intervention (exercise) arm will undergo an individualised assessment by either a physiotherapist or a qualified exercise specialist with specialised exercise and health condition qualifications. Following this initial assessment, patients will receive a tailored exercise, wellbeing and nutritional support package. The investigators will assess functional fitness and health-related quality of life scores as study outcome measures. The investigators also aim to conduct semi-structured interviews in patients who decline to participate or drop out of the study in order to examine barriers to study recruitment and retention.

Interventions

OTHERExercise Therapy

12 week personalised exercise, nutrition and wellbeing programme

Sponsors

University of Surrey
CollaboratorOTHER
Manchester University NHS Foundation Trust
CollaboratorOTHER_GOV
Mesothelioma UK
CollaboratorUNKNOWN
NHS Greater Glasgow and Clyde
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Masking description

Open label, no masking

Intervention model description

1:1 randomisation, feasibility study

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Diagnosis of mesothelioma, ratified by a mesothelioma multi-disciplinary team (MDT) meeting 2. Performance status 0 - 2 3. Clinical frailty score ≤5 4. Informed written consent

Exclusion criteria

1. Performance status ≥3 2. Clinical frailty score ≥6 3. Unlikely to be able to participate in an exercise programme (clinician/physiotherapist judgement)

Design outcomes

Primary

MeasureTime frameDescription
Number of patients recruited12 monthsNumber of patients recruited to the study

Secondary

MeasureTime frameDescription
Intervention adherence rate12 monthsProportion of patients randomised to the intervention arm who complete the exercise programme
Proportion of screened patients who are ineligible12 monthsProportion of screened patients who are ineligible for the study
Study drop-out rate12 monthsProportion of patients who enter the study who withdraw prior to study completion
Health-related Quality of Life questionnaire completion rate18 monthsNumber of Health-related Quality of Life questionnaires completed by participants in the study (higher numbers of completed questionnaires equates to better outcome)
Framework analysis from qualitative interviews12 monthsFramework analysis from qualitative interviews with study participants

Countries

United Kingdom

Contacts

Primary ContactSelina Tsim, PhD
Selina.Tsim@glasgow.ac.uk0141 451 6163

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026